Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ovarian Neoplasms

Free Subscription 22.03.2021 2 Anticancer Drugs 3 Br J Cancer 1 Cancer 6 Gynecol Oncol 1 J Natl Cancer Inst

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Anticancer Drugs

1. WEI S, Qi L, Wang L
   Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
   Anticancer Drugs. 2021 Mar 16. pii: 00001813-900000000-98432.
   PubMed         Abstract available
   
   
2. HU H, Zhu S, Tong Y, Huang G, et al
   Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro.
   Anticancer Drugs. 2020;31:483-491.
   PubMed         Abstract available
   
   

   
   Br J Cancer

3. LEPAGE CC, Palmer MCL, Farrell AC, Neudorf NM, et al
   Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer.
   Br J Cancer. 2021 Mar 17. pii: 10.1038/s41416-021-01317.
   PubMed         Abstract available
   
   
4. ZHANG X, Ling MT, Feng H, Wong YC, et al
   Retraction Note to: Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells.
   Br J Cancer. 2021 Mar 15. pii: 10.1038/s41416-021-01322.
   PubMed        
   
   
5. MONTFORT A, Owen S, Piskorz AM, Supernat A, et al
   Combining measures of immune infiltration shows additive effect on survival prediction in high-grade serous ovarian carcinoma.
   Br J Cancer. 2020 Apr 6. pii: 10.1038/s41416-020-0822.
   PubMed         Abstract available
   
   

   
   Cancer

6. LEE CK, Friedlander ML, Tjokrowidjaja A, Ledermann JA, et al
   Molecular and clinical predictors of improvement in progression-free survival with maintenance PARP inhibitor therapy in women with platinum-sensitive, recurrent ovarian cancer: A meta-analysis.
   Cancer. 2021 Mar 19. doi: 10.1002/cncr.33517.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

7. BUECHEL ME, Enserro D, Burger RA, Brady MF, et al
   Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
   Gynecol Oncol. 2021 Mar 9. pii: S0090-8258(21)00177.
   PubMed         Abstract available
   
   
8. LAGO V, Montero B, Lopez S, Padilla-Iserte P, et al
   Ultrastaging protocol in sentinel lymph node for apparent early stage ovarian cancer.
   Gynecol Oncol. 2021 Mar 9. pii: S0090-8258(21)00193.
   PubMed         Abstract available
   
   
9. MORDEN CR, Farrell AC, Sliwowski M, Lichtensztejn Z, et al
   Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples.
   Gynecol Oncol. 2021 Mar 10. pii: S0090-8258(21)00199.
   PubMed         Abstract available
   
   
10. ROCCONI RP, Monk BJ, Walter A, Herzog TJ, et al
    Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer.
    Gynecol Oncol. 2021 Mar 11. pii: S0090-8258(21)00229.
    PubMed         Abstract available
    
    
11. HASSELGREN E, Hertzberg D, Camderman T, Bjorne H, et al
    Perioperative fluid balance and major postoperative complications in surgery for advanced epithelial ovarian cancer.
    Gynecol Oncol. 2021 Mar 12. pii: S0090-8258(21)00179.
    PubMed         Abstract available
    
    
12. LOREEN A, Polen-De C, Monk BJ, Jackson AL, et al
    The role of blinded independent radiologic review in ovarian cancer clinical trials: Discerning the value.
    Gynecol Oncol. 2021 Mar 12. pii: S0090-8258(21)00176.
    PubMed        
    
    

    
    J Natl Cancer Inst

13. WENZEL L, Osann K, McKinney C, Cella D, et al
    Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.
    J Natl Cancer Inst. 2021 Mar 17. pii: 6174697. doi: 10.1093.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: